1Brugger W, Heimfeld S, Berenson RJ,et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med, 1995,333:283-287.
2Alcorn MJ, Holyoake TL, Richmond L, et al. CD34+cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity. J Clin Oncol ,1996, 14:1839-1847.
3Norol F, Drouet M,Mathieu J,et al . Ex vivo expanded mobilized peripheral blood CD34+ cells accelerate hematological recovery in a baboon model of autologous transplantation. Br J Haematol, 2000,109:162-172.
4Shpall EJ, Quinones R,Giller R, et al. Transplantation of adult and pediatric cancer patients with cord blood progenitors expanded ex vivo. Blood, 2000,96 Suppl:207a.
5Andrews RG, Briddell RA, Hill R, et al. Engraftment of primates with G-CSF mobilized peripheral blood CD34+progenitor cells expanded in G-CSF, SCF and MGDF decrease the duration and severity of neutropenia. Stem Cells, 1999, 17: 210-218.
6Paquette RL, Dergham ST,Karpf E, et al. Ex vivo expansion unselected peripheral blood :progenitor cells reduce posttransplantation neutropenia, thrombo-cytopenia, and anemia in patients with breast cancer. Blood, 2000,96:2385-2390.
7McNiece L, Scott l RJ, Cagnoni BP, et al. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood,2000,96:3001-3007.
9Stiff P, Chen B, Franklin W, et al. Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer. Blood,2000,95:2169-2174.
10Engelhardt M, Douville J, Behringer D, et al. hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myloablative chemotherapy. Bone Marrow Transplant,2001, 27:249-259.
